Interaction with Ppil3 leads to the cytoplasmic localization of Apoptin in tumor cells

Biochemical and Biophysical Research Communications

Volumn 372, Issue 1, 2008, Pages 14-18

  Huo, De Hua ^a   Yi, Li Na ^a   Yang, Jine ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

APOPTIN; Cancer specificity; Nuclearcytoplasmic shuffling; Peptidyl prolyl cis trans isomerase; PPIL3; Protein protein interaction

Indexed keywords

APOPTIN; PEPTIDYLPROLYL ISOMERASE LIKE 3 PROTEIN; PROTEIN DERIVATIVE;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; CAPSID PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLOPHILINS; CYTOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; TWO-HYBRID SYSTEM TECHNIQUES;

CHICKEN ANEMIA VIRUS;

EID: 44649130002     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.04.178     Document Type: Article

References (33)

1. Danen-Van Oorschot A.A., Fischer D.F., Grimbergen J.M., Klein B., Zhuang S.M., Falkenburg J.H., Backendorf C., Quax P.H., Van der Eb A.J., and Noteborn M.H. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc. Natl. Acad. Sci. USA 94 (1997) 5843-5847
2. Zhuang S.M., Shvarts A., van Ormondt H., Jochemsen A.G., van der Eb A.J., and Noteborn MH. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res. 55 (1995) 486-489
3. Zhuang S.M., Shvarts A., Jochemsen A.G., van Oorschot A.A., van der Eb A.J., and Noteborn M.H. Differential sensitivity to Ad5 E1B-21kD and Bcl-2 proteins of Apoptin-induced versus p53-induced apoptosis. Carcinogenesis 16 (1995) 2939-2944
4. Danen-Van Oorschot A.A., Zhang Y., Erkeland S.J., Fischer D.F., van der Eb A.J., and Noteborn M.H. The effect of Bcl-2 on Apoptin in 'normal' vs transformed human cells. Leukemia 13 (1999) S75-S77
5. Danen-Van Oorschot A.A., Zhang Y.H., Leliveld S.R., Rohn J.L., Seelen M.C., Bolk M.W., Van Zon A., Erkeland S.J., Abrahams J.P., Mumberg D., and Noteborn M.H. Importance of nuclear localization of Apoptin for tumor-specific induction of apoptosis. J. Biol. Chem. 278 (2003) 27729-27736
6. Guelen L., Paterson H., Gaken J., Meyers M., Farzaneh F., and Tavassoli M. TAT-Apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23 (2004) 1153-1165
7. Rohn J.L., Zhang Y.H., Aalbers R.I., Otto N., Den Hertog J., Henriquez N.V., Van De Velde C.J., Kuppen P.J., Mumberg D., Donner P., and Noteborn M.H. A tumor-specific kinase activity regulates the viral death protein Apoptin. J. Biol. Chem. 277 (2002) 50820-50827
8. Poon I.K., Oro C., Dias M.M., Zhang J.P., and Jans D.A. A tumor cell-specific nuclear targeting signal within chicken anemia virus VP3/Apoptin. J. Virol. 79 (2005) 1339-1341
9. Poon I.K., Oro C., Dias M.M., Zhang J., and Jans D.A. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 65 (2005) 7059-7064
10. S. Heckl, M. Regenbogen, A. Sturzu, A. Gharabaghi, G. Feil, A. Beck, H. Echner, T. Nagele, Value of Apoptin's 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells, Apoptosis, 2008 [Epub ahead of print].
11. Danen-van Oorschot A.A., Voskamp P., Seelen M.C., van Miltenburg M.H., Bolk M.W., Tait S.W., Boesen-de Cock J.G., Rohn J.L., Borst J., and Noteborn M.H. Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing. Cell Death Differ. 11 (2004) 564-573
12. Maddika S., Booy E.P., Johar D., Gibson S.B., Ghavami S., and Los M. Cancer-specific toxicity of Apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J. Cell Sci. 118 (2005) 4485-4493
13. Sun G.J., Tong X., Dong Y., Mei Z.Z., and Sun Z.X. Identification of a protein interacting with Apoptin from human leucocyte cDNA library by using yeast two-hybrid screening. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34 (2002) 369-372
14. Cheng C.M., Huang S.P., Chang Y.F., Chung W.Y., and You C.Y. The viral death protein Apoptin interacts with Hippi, the protein interactor of Huntingtin-interacting protein 1. Biochem. Biophys. Res. Commun. 305 (2003) 359-364
15. Maddika S., Bay G.H., Kroczak T.J., Ande S.R., Maddika S., Wiechec E., Gibson S.B., and Los M. Akt is transferred to the nucleus of cells treated with Apoptin, and it participates in Apoptin-induced cell death. Cell Prolif. 40 (2007) 835-848
16. Zhou Z., Ying K., Dai J., Tang R., Wang W., Huang Y., Zhao W., Xie Y., and Mao Y. Molecular cloning and characterization of a novel peptidylprolyl isomerase (cyclophilin)-like gene (Ppil3) from human fetal brain. Cytogenet. Cell Genet. 92 (2001) 231-236
17. Hu H., Huang C.Q., Liu H.L., Han Y., Yu L., and Bi R.C. Crystallization and preliminary X-ray crystallographic studies of human cyclophilin J. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61 (2005) 216-218
18. Fischer G., Bang H., and Mech C. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed. Biochim. Acta 43 (1984) 1101-1111
19. Yao Q., Li M., Yang H., Chai H., Fisher W., and Chen C. Roles of cyclophilins in cancers and other organ systems. World J. Surg. 29 (2005) 276-280
20. Lin D.T., and Lechleiter J.D. Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J. Biol. Chem. 277 (2002) 31134-31141
21. Capano M., Virji S., and Crompton M. Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells. Biochem. J. 363 (2002) 29-36
22. Woodfield K., Rück A., Brdiczka D., and Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 336 (1998) 287-290
23. Bram R.J., and Crabtreet G.R. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein. Nature 371 (1994) 355-358
24. Ward B.K., Mark P.J., Ingram D.M., Minchin R.F., and Ratajczak T. Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 58 (1999) 267-280
25. Kumar P., Mark P.J., Ward B.K., Minchin R.F., and Ratajczak T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 284 (2001) 219-225
26. Ward B.K., Kumar P., Turbett G.R., Edmondston J.E., Papadimitriou J.M., Laing N.G., Ingram D.M., Minchin R.F., and Ratajczak T. Allelic loss of cyclophilin 40, an estrogen receptor-associated immunophilin, in breast carcinomas. J. Cancer Res. Clin. Oncol. 127 (2001) 109-115
27. Campa M.J., Wang M.Z., Howard B., Fitzgerald M.C., and Patz Jr. E.F. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res. 63 (2003) 1652-1656
28. Gomi S., Nakao M., Niiya F., Imamura Y., Kawano K., Nishizaka S., Hayashi A., Sobao Y., Oizumi K., and Itoh K. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J. Immunol. 163 (1999) 4994-5004
29. Gohara R., Imai N., Rikimaru T., Yamada A., Hida N., Ichiki M., Kawamoto M., Matsunaga K., Ashihara J., Yano S., Tamura M., Ohkouchi S., Yamana H., Oizumi K., and Itoh K. Phase 1 clinical study of cyclophilin B peptide vaccine for patients with lung cancer. J. Immunother. 25 (2002) 439-444
30. Teodoro J.G., Heilman D.W., Parker A.E., and Green M.R. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 18 (2004) 1952-1957
31. Leliveld S.R., Dame R.T., Mommaas M.A., Koerten H.K., Wyman C., Danen-van Oorschot A.A., Rohn J.L., Noteborn M.H., and Abrahams J.P. Apoptin protein multimers form distinct higher-order nucleoprotein complexes with DNA. Nucleic Acids Res. 31 (2003) 4805-4813
32. Leliveld S.R., Zhang Y.H., Rohn J.L., Noteborn M.H., and Abrahams J.P. Apoptin induces tumor-specific apoptosis as a globular multimer. J. Biol. Chem. 278 (2003) 9042-9051
33. Backendorf C., Visser A.E., de Boer A.G., Zimmerman R., Visser M., Voskamp P., Zhang Y.H., and Noteborn M. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 143-169